InsidersTradesSigma
Track the 益丰药房 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 益丰药房 has logged 7 insider filings. Market capitalisation: €27.6bn. The latest transaction was disclosed on 5 March 2026 (Sale). Among the most active insiders: 肖再祥. All data is openly available.
7
Insider Decl.
n/a
Thresholds
€10,965
1 ops.
Buy Volume
€59m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,752 of 29,064 companies
71.4
score / 100
Value78
Quality65
FCF yld11%
Earn yld6.1%
EV/EBITDA7.3x
ROE15%
Gross mgn39%
Net mgn6.9%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2026
Declarations7 total
21,471,900 sharesA股XSHGSSE:173000009320124640
7 of 7 declarations
Acerca de 益丰药房
益丰药房 es una cadena de farmacias en China, especializada en la venta de medicamentos y productos para la salud. Opera principalmente en el mercado de la salud y farmacéutico.